165
Views
61
CrossRef citations to date
0
Altmetric
Original Research

Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells

, , &
Pages 7669-7680 | Published online: 19 Nov 2018

References

  • RoserMRitchieHCancer Published online at OurWorldInData.org. Available from: https://ourworldindata.org/cancerAccessed October 12, 2018
  • GBDCauses of death collaboratorsLancet201620173901151
  • ZhangDXuQWangNA complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growthInt J Nanomedicine201813134549456130127606
  • XuPZuoHChenBDoxorubicin-loaded platelets as a smart drug delivery system: an improved therapy for lymphomaSci Rep201774263228198453
  • DittoAJShahKNRobishawNKPanznerMJYoungsWJYunYHThe interactions between L-tyrosine based nanoparticles decorated with folic acid and cervical cancer cells under physiological flowMol Pharm20129113089309822957928
  • De JongWHBormPJDrug delivery and nanoparticles: applications and hazardsInt J Nanomedicine20083213314918686775
  • ArgyoCWeissVBräuchleCBeinTMultifunctional mesoporous silica nanoparticles as a universal platform for drug deliveryChem Mater2014261435451
  • MamaevaVSahlgrenCLindénMMesoporous silica nanoparticles in medicine – recent advancesAdv Drug Deliv Rev201365568970222921598
  • BahramiBHojjat-FarsangiMMohammadiHNanoparticles and targeted drug delivery in cancer therapyImmunol Lett2017190648328760499
  • YousefpourPAtyabiFVasheghani-FarahaniEMovahediAADinarvandRTargeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumabInt J Nanomedicine201161977199021976974
  • DostalovaSCernaTHynekDSite-directed conjugation of antibodies to apoferritin nanocarrier for targeted drug delivery to prostate cancer cellsACS Appl Mater Interfaces2016823144301444127219717
  • WangCWangXZhongTThe antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivoInt J Nanomedicine2015102229224825834435
  • LiuYChenQXuMSingle peptide ligand-functionalized uniform hollow mesoporous silica nanoparticles achieving dual-targeting drug delivery to tumor cells and angiogenic blood vessel cellsInt J Nanomedicine2015101855186725834425
  • HanYZhangYLiDChenYSunJKongFTransferrin-modified nano-structured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicinInt J Nanomedicine201494107411625187713
  • NukolovaNVOberoiHSZhaoYChekhoninVPKabanovAVBronichTKLHRH-targeted nanogels as a delivery system for cisplatin to ovarian cancerMol Pharm201310103913392123957812
  • LimontaPMontagnani MarelliMMaiSMottaMMartiniLMorettiRMGnRH receptors in cancer: from cell biology to novel targeted therapeutic strategiesEndocr Rev201233578481122778172
  • SchallyAVArimuraAKastinAJGonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormonesScience19711734001103610384938639
  • KakarSSJinHHongBEatonJWKangKALHRH receptor targeted therapy for breast cancerAdv Exp Med Biol200861428529618290339
  • KumarPTambePPaknikarKMGajbhiyeVFolate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: a comparative studyColloids Surf B Biointerfaces201715620321228531877
  • TambePKumarPKarpeYAPaknikarKMGajbhiyeVTriptorelin tethered multifunctional PAMAM-histidine-PEG nanoconstructs enable specific targeting and efficient gene silencing in LHRH overexpressing cancer cellsACS Appl Mater Interfaces2017941355623557328949503
  • ChatterjeeBGhoshalAChattopadhyayAGhoshSSdGTP-templated luminescent gold nanocluster-based composite nanoparticles for cancer theranosticsACS Biomater Sci Eng20184310051012
  • ZhengXWangCDaiJShiWYanYDesign of mesoporous silica hybrid materials as sorbents for the selective recovery of rare earth metalsJ Mater Chem A Mater20153191032710335
  • VarshosazJJahanian-NajafabadiAGhazzaviJLuteinizing hormone-releasing hormone targeted poly(methyl vinyl ether maleic acid) nanoparticles for doxorubicin delivery to MCF-7 breast cancer cellsIET Nanobiotechnol201610420621427463791
  • FraschiniCJalabertMPrud’hommeREPhysical characterization of blends of poly(D-lactide) and LHRH (a leuprolide decapeptide analog)Biomacromolecules2005663112311816283735
  • MohanPRapoportNDoxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear traffickingMol Pharm2010761959197320957997
  • KumarPTambePPaknikarKMGajbhiyeVMesoporous silica nanoparticles as cutting-edge theranostics: Advancement from merely a carrier to tailor-made smart delivery platformJ Control Release2018287353730125637
  • ParkSMAalipourAVermeshOYuJHGambhirSSTowards clinically translatable in vivo nanodiagnosticsNat Rev Mater201725170141702029876137
  • LehmanSEMudunkotuwaIAGrassianVHLarsenSCNano–bio interactions of porous and nonporous silica nanoparticles of varied surface chemistry: a structural, kinetic, and thermodynamic study of protein adsorption from RPMI culture mediumLangmuir201632373174226716353
  • CaudaVEngelkeHSauerAColchicine-loaded lipid bilayer-coated 50 nm mesoporous nanoparticles efficiently induce microtubule depolymerization upon cell uptakeNano Lett20101072484249220515041
  • LiuKLiuPCLiuRWuXDual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometryMed Sci Monit Basic Res201521152025664686
  • KumarPPaknikarKMGajbhiyeVA robust pH-sensitive unimolecular dendritic nanocarrier that enables targeted anti-cancer drug delivery via GLUT transportersColloids Surf B Biointerfaces201817143744430075419